[unable to retrieve full-text content]

The likes of Pfizer and Lilly have announced the halting of research in light of Moscow’s offensive against Ukraine Several major international pharmaceutical companies including Pfizer, Lilly and Sanofi have issued statements, announcing the suspension of new clinical trials in Russia in light of its military campaign against Ukraine.

With Kiev’s defenses unraveling, the narrative surrounding the country’s leader has suddenly changed in Western media By Glenn Diesen, Professor at the University of South-Eastern Norway and an editor at the Russia in Global Affairs journal. Follow him on Twitter @glenndiesen.